Literature DB >> 25575985

Obstetric and perinatal outcome in type 1 diabetes patients with diabetic nephropathy during 1988-2011.

Miira M Klemetti1, Hannele Laivuori, Minna Tikkanen, Mika Nuutila, Vilho Hiilesmaa, Kari Teramo.   

Abstract

AIMS/HYPOTHESIS: Our aim was to analyse possible changes in the glycaemic control, BP, markers of renal function, and obstetric and perinatal outcomes of parturients with diabetic nephropathy during 1988-2011.
METHODS: The most recent childbirth of 108 consecutive type 1 diabetes patients with diabetic nephropathy and a singleton pregnancy were studied. Two periods, 1988-1999 and 2000-2011, were compared.
RESULTS: The prepregnancy and the first trimester median HbA1c values persisted at high levels (8.2% [66 mmol/mol] vs 8.5% [69 mmol/mol], p = 0.16 and 8.3% [67 mmol/mol] vs 8.4% [68 mmol/mol], p = 0.67, respectively), but decreased by mid-pregnancy (6.7% [50 mmol/mol] vs 6.9% [52 mmol/mol], p = 0.11). Antihypertensive medication usage increased before pregnancy (34% vs 65%, p = 0.002) and in the second and third trimesters of pregnancy (25% vs 47%, p = 0.02, and 36% vs 60%, p = 0.01, respectively). BP exceeded 130/80 mmHg in 62% and 61% (p = 0.87) of patients in the first trimester, and in 95% and 93% (p = 0.69) in the third trimester, respectively. No changes were observed in the markers of renal function. Pre-eclampsia (52% vs 42%, p = 0.29) and preterm birth rates before 32 and 37 gestational weeks (14% vs 21%, p = 0.33, and 71% vs 77%, p = 0.49, respectively) remained high. The elective and emergency Caesarean section rates were 71% and 45% (p = 0.01) and 29% and 48% (p = 0.05), respectively. Neonatal intensive care unit admissions increased from 26% to 49% (p = 0.02). CONCLUSIONS/
INTERPRETATION: Early pregnancy glycaemic control and hypertension management were suboptimal in both time periods. Pre-eclampsia and preterm delivery rates remained high in patients with diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25575985     DOI: 10.1007/s00125-014-3488-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  39 in total

1.  Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2014-12-02       Impact factor: 25.391

2.  Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery.

Authors:  Darcy B Carr; Gretchen L Koontz; Carolyn Gardella; Emily V Holing; Debra A Brateng; Zane A Brown; Thomas R Easterling
Journal:  Am J Hypertens       Date:  2006-05       Impact factor: 2.689

3.  A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes.

Authors:  L J Scott; J H Warram; L S Hanna; L M Laffel; L Ryan; A S Krolewski
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

4.  Pregnancy outcome in type 1 diabetic women with microalbuminuria.

Authors:  P Ekbom; P Damm; B Feldt-Rasmussen; U Feldt-Rasmussen; J Mølvig; E R Mathiesen
Journal:  Diabetes Care       Date:  2001-10       Impact factor: 19.112

5.  Factors associated with preterm delivery in women with type 1 diabetes: a cohort study.

Authors:  Jacques Lepercq; Joel Coste; Anne Theau; Daniele Dubois-Laforgue; Jose Timsit
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

Review 6.  Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach.

Authors:  Marshall D Lindheimer; David Kanter
Journal:  Obstet Gynecol       Date:  2010-02       Impact factor: 7.661

7.  Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Authors: 
Journal:  JAMA       Date:  2003-10-22       Impact factor: 56.272

Review 8.  Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment.

Authors:  Elisabeth R Mathiesen; Lene Ringholm; Bo Feldt-Rasmussen; Peter Clausen; Peter Damm
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-23       Impact factor: 8.237

9.  Diabetic nephropathy and perinatal outcome.

Authors:  J L Kitzmiller; E R Brown; M Phillippe; A R Stark; D Acker; A Kaldany; S Singh; J W Hare
Journal:  Am J Obstet Gynecol       Date:  1981-12-01       Impact factor: 8.661

10.  Diabetic nephropathy: pregnancy performance and fetomaternal outcome.

Authors:  E A Reece; D R Coustan; J P Hayslett; T Holford; J Coulehan; T Z O'Connor; J C Hobbins
Journal:  Am J Obstet Gynecol       Date:  1988-07       Impact factor: 8.661

View more
  13 in total

1.  Diabetic nephropathy in pregnancy: new insights from a retrospective cohort study.

Authors:  Elisabeth R Mathiesen
Journal:  Diabetologia       Date:  2015-02-18       Impact factor: 10.122

Review 2.  Pregnancy in women with diabetic nephropathy.

Authors:  Donatella Spotti
Journal:  J Nephrol       Date:  2018-11-15       Impact factor: 3.902

3.  White's classification and pregnancy outcome in women with type 1 diabetes: a population-based cohort study.

Authors:  Miira M Klemetti; Hannele Laivuori; Minna Tikkanen; Mika Nuutila; Vilho Hiilesmaa; Kari Teramo
Journal:  Diabetologia       Date:  2016-01       Impact factor: 10.122

Review 4.  Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding.

Authors:  Lene Ringholm; Julie Agner Damm; Marianne Vestgaard; Peter Damm; Elisabeth R Mathiesen
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

Review 5.  Improving pregnancy outcomes in women with diabetes mellitus: modern management.

Authors:  Lene Ringholm; Peter Damm; Elisabeth R Mathiesen
Journal:  Nat Rev Endocrinol       Date:  2019-07       Impact factor: 43.330

Review 6.  Reproductive health and pregnancy in women with chronic kidney disease.

Authors:  Kate S Wiles; Catherine Nelson-Piercy; Kate Bramham
Journal:  Nat Rev Nephrol       Date:  2018-01-22       Impact factor: 28.314

7.  Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes.

Authors:  Clare B Kelly; Michelle B Hookham; Jeremy Y Yu; Alicia J Jenkins; Alison J Nankervis; Kristian F Hanssen; Satish K Garg; James A Scardo; Samar M Hammad; M Kathryn Menard; Christopher E Aston; Timothy J Lyons
Journal:  Diabetes Care       Date:  2017-11-09       Impact factor: 19.112

8.  Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes.

Authors:  Julie C Søholm; Marianne Vestgaard; Björg Ásbjörnsdóttir; Nicoline C Do; Berit W Pedersen; Lone Storgaard; Birgitte B Nielsen; Lene Ringholm; Peter Damm; Elisabeth R Mathiesen
Journal:  Diabetologia       Date:  2021-06-19       Impact factor: 10.122

9.  Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetes.

Authors:  Martina Persson; Sven Cnattingius; Anna-Karin Wikström; Stefan Johansson
Journal:  Diabetologia       Date:  2016-07-01       Impact factor: 10.122

Review 10.  The Immunogenetic Conundrum of Preeclampsia.

Authors:  A Inkeri Lokki; Jenni K Heikkinen-Eloranta; Hannele Laivuori
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.